)
India’s Sun Pharma to buy Organon for $11.75 billion, signals global expansion beyond generics
Published on: April 27, 2026, 7:43 a.m. | Source: Firstpost
Sun Pharma’s $11.75 billion acquisition of Organon marks a major global expansion, giving the Indian drugmaker scale in biosimilars and women’s health while signalling a shift beyond generics
